T ACUTE LYMPHOBLASTIC LEUKEMIA
Clinical trials for T ACUTE LYMPHOBLASTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new T ACUTE LYMPHOBLASTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for T ACUTE LYMPHOBLASTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New 'Living Drug' trial aims to stop aggressive childhood cancers from returning
Disease control Not yet recruitingThis early-phase study is testing a new type of CAR-T cell therapy for children and teenagers with high-risk T-cell leukemia or lymphoma. The goal is to see if collecting a patient's own immune cells, modifying them to target cancer, and reinfusing them can safely prevent the can…
Matched conditions: T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Major trial aims to boost cure rates for aggressive childhood cancers
Disease control Not yet recruitingThis study is for children and young adults newly diagnosed with T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LL). It will test if adding a targeted drug called daratumumab to standard chemotherapy helps patients stay cancer-free longer and impr…
Matched conditions: T ACUTE LYMPHOBLASTIC LEUKEMIA
Phase: PHASE2, PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC